WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MRK

Based on 9 analysts offering 12 month price targets for Merck & Co Inc

Min Forecast
$84.00+0.77%
Avg Forecast
$104.00+24.76%
Max Forecast
$122.00+46.35%

Should I buy or sell MRK stock?

Based on 9 analysts offering ratings for Merck & Co Inc.

Buy
Strong Buy
3 analysts 33.33%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MRK's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates MRK as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their MRK stock forecasts and price targets.

MRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-10
lockedlocked$00.00+00.00%2025-05-14
lockedlocked$00.00+00.00%2025-04-22Find Out Why
lockedlocked$00.00+00.00%2025-04-17
lockedlocked$00.00+00.00%2025-02-18Find Out Why
Bank of America
Top 28%
73
Strong BuyMaintains$112.00+34.36%2025-02-05Find out why
BMO Capital
Top 26%
75
HoldMaintains$96.00+15.16%2025-02-05Find out why
Guggenheim
Top 12%
89
Strong BuyMaintains$122.00+46.35%2025-01-17
Leerink Partners
Bottom 1%
1
BuyMaintains$119.00+42.75%2025-01-13

1 of 1

Forecast return on equity

Is MRK forecast to generate an efficient return?

Company
59.19%
Industry
355.95%
Market
89.88%
MRK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MRK forecast to generate an efficient return on assets?

Company
24.85%
Industry
25.06%
MRK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MRK earnings per share forecast

What is MRK's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$8.88+28.91%
Avg 2 year Forecast
$9.67+40.3%
Avg 3 year Forecast
$10.73+55.72%
MRK's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MRK revenue forecast

What is MRK's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$64.8B+1.37%
Avg 2 year Forecast
$68.4B+7.08%
Avg 3 year Forecast
$72.8B+13.92%
MRK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MRK earnings growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
15.66%
Industry
35.79%
Market
15.82%
MRK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MRK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MRK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MRK revenue growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
4.38%
Industry
7.27%
Market
10.4%
MRK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MRK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MRK vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
MRK$83.36$104.00+24.76%Buy
AZN$71.13N/AN/A
NVS$121.02N/AN/A
AMGN$295.27$310.91+5.30%Hold
PFE$25.65$27.33+6.56%Hold
View Top General Drug Manufacturer Stocks

Merck & Co Stock Forecast FAQ

Is Merck & Co Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: MRK) stock is to Buy MRK stock.

Out of 9 analysts, 3 (33.33%) are recommending MRK as a Strong Buy, 1 (11.11%) are recommending MRK as a Buy, 5 (55.56%) are recommending MRK as a Hold, 0 (0%) are recommending MRK as a Sell, and 0 (0%) are recommending MRK as a Strong Sell.

If you're new to stock investing, here's how to buy Merck & Co stock.

What is MRK's earnings growth forecast for 2025-2027?

(NYSE: MRK) Merck & Co's forecast annual earnings growth rate of 15.66% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 35.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.

Merck & Co's earnings in 2025 is $17,434,000,000.On average, 10 Wall Street analysts forecast MRK's earnings for 2025 to be $22,301,975,177, with the lowest MRK earnings forecast at $21,745,530,651, and the highest MRK earnings forecast at $22,724,832,840. On average, 10 Wall Street analysts forecast MRK's earnings for 2026 to be $24,274,139,123, with the lowest MRK earnings forecast at $22,423,509,089, and the highest MRK earnings forecast at $25,938,952,843.

In 2027, MRK is forecast to generate $26,941,356,520 in earnings, with the lowest earnings forecast at $24,884,319,717 and the highest earnings forecast at $29,630,168,785.

What is MRK's revenue growth forecast for 2025-2027?

(NYSE: MRK) Merck & Co's forecast annual revenue growth rate of 4.38% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.

Merck & Co's revenue in 2025 is $63,922,000,000.On average, 6 Wall Street analysts forecast MRK's revenue for 2025 to be $162,707,839,505,454, with the lowest MRK revenue forecast at $161,173,052,005,058, and the highest MRK revenue forecast at $164,727,065,199,304. On average, 6 Wall Street analysts forecast MRK's revenue for 2026 to be $171,876,272,500,345, with the lowest MRK revenue forecast at $167,705,351,658,894, and the highest MRK revenue forecast at $176,578,228,742,213.

In 2027, MRK is forecast to generate $182,857,479,221,527 in revenue, with the lowest revenue forecast at $177,607,274,460,005 and the highest revenue forecast at $190,373,834,446,195.

What is MRK's forecast return on assets (ROA) for 2025-2028?

(NYSE: MRK) forecast ROA is 24.85%, which is lower than the forecast US Drug Manufacturers - General industry average of 25.06%.

What is MRK's Price Target?

According to 9 Wall Street analysts that have issued a 1 year MRK price target, the average MRK price target is $104.00, with the highest MRK stock price forecast at $122.00 and the lowest MRK stock price forecast at $84.00.

On average, Wall Street analysts predict that Merck & Co's share price could reach $104.00 by Jul 10, 2026. The average Merck & Co stock price prediction forecasts a potential upside of 24.76% from the current MRK share price of $83.36.

What is MRK's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: MRK) Merck & Co's current Earnings Per Share (EPS) is $6.89. On average, analysts forecast that MRK's EPS will be $8.88 for 2025, with the lowest EPS forecast at $8.66, and the highest EPS forecast at $9.05. On average, analysts forecast that MRK's EPS will be $9.67 for 2026, with the lowest EPS forecast at $8.93, and the highest EPS forecast at $10.33. In 2027, MRK's EPS is forecast to hit $10.73 (min: $9.91, max: $11.80).

What is MRK's forecast return on equity (ROE) for 2025-2028?

(NYSE: MRK) forecast ROE is 59.19%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.